People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanoviricides, Inc. | — | Pharmaceuticals | Series A | $14.5M | $16.8M | 2013 |
Anil Diwan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anil Diwan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stanley Glick | 1 | 3 |
| Makarand Jawadekar | 1 | 2 |
| Meeta Vyas | 1 | 1 |
| Theodore Edward Rokita | 1 | 1 |
| Zucker Edward Brian | 1 | 1 |
| Mukund Kulkarni | 1 | 1 |
| Milton Boniuk | 1 | 1 |
| Eugene Seymour | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.